Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-27.23	182.51	250.81
Graham Fair Price	-58.07	12.69	30.27
PEG	1524.55	-1.37	0.08
Price/Book	-41.82	8.18	14.06
Price/Cash Flow	-51.34	-207.74	426.88
Prices/Earnings	320.01	116.61	27.76
Price/Sales	-29.35	24.72	34.99
Price/FCF	-51.34	-207.74	426.88
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.60	0.17	0.18
Operating Margin	-32.97	0.05	0.08
ROA	-86.10	0.01	0.07
ROE	0.13	0.02	-86.15
ROIC	0.10	0.01	-88.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	1.18	-97.01
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.17	-0.43	154.40
EPS QOQ	3.29	-0.85	-74.15
FCF QOQ	1.43	-2.23	55.56
Revenue QOQ	0.08	-0.15	97.41
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	59.16	81.96	38.54
Days Sales Outstanding (DSO)	12.54	16.42	30.91
Inventory Turnover	1.52	1.10	-27.82
Debt/Capitalization	0.13	0.13	0.63
Quick Ratio	1.13	1.04	-7.94
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17.94	20.21	12.66
Cash	8.33	8.43	1.20
Capex	-0.66	-0.87	-31.93
Free Cash Flow	0.59	-0.80	34.68
Revenue	7.21	6.69	-7.23
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.73	1.72	-0.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.96	-0.66	66.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating